Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.

Hana M El SahlyInci YildirimSharon E FreyPatricia WinokurLisa A JacksonDavid I BernsteinC Buddy CreechWilbur H ChenRichard E RuppJennifer A WhitakerVarun PhadkeDaniel F HoftDilek InceRebecca C BradyKathryn M EdwardsJustin R OrtizMegan A BermanJulia WeissAshley Wegelnull null

Published in: The Journal of infectious diseases (2023)

Serologic responses to a heterologous A(H7N9) MIV boost were highest in participants primed and boosted with adjuvant-containing regimens.

Keyphrases

saccharomyces cerevisiae
early stage
respiratory syndrome coronavirus
coronavirus disease